AFIB technology detects AF with a high sensitivity (97-100%) and specificity
(89%), as demonstrated by two recent comparison studies with electrocardiogram
involving 500 patients
State-of-the-art technology patented by Microlife allows
for easy Atrial Fibrillation screening at home with a simple
blood pressure measurement.
Dr Stergiou, who is among the most important researchers
in Europe, has stated in the conclusion of the clinical study
on MICROLIFE AFIB technology that:
“These data suggest that an electronic device for selfhome
BP monitoring, which implements an algorithm for
AF diagnosis, has an excellent diagnostic accuracy and
might, therefore, be used as a reliable screening test for
the early diagnosis”.
Dr. G.S. Stergiou, Hypertension Center, Sotiria Hospital, Athens Greece
MICROLIFE AFIB technology does not perform a diagnosis.
It represents a suitable and reliable support for screening
ATRIAL FIBRILLATION among the population for
STROKE prevention
It is particularly suitable to identify ATRIAL FIBRILLATION
in asymptomatic patients.
It is further suitable for follow-up at home of HYPERTENSIVE
PATIENTS with ATRIAL FIBRILLATION.
A 200 Afib Features
Blood pressure & pulse measurement
Detection of atrial fibrillation (specific heart arrhythmia)
Clinically tested (BHS protocol)
MAM technology (automatic triple measurement)
200 Data memory with time and date
XL-Display
Equipped with carrying bag
Low battery indication
Rechargeable battery-friendly
Mains adapter port
Optional: USB PC link and Software
Recommended by doctors
Equipped with world’s latest technologies
Medically reliable measurements with AFIB & MAM
No comments:
Post a Comment